JP Morgan Private Wealth Advisors’s Medicines Co MDCO Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,745	Closed	-$318K	–	1582
2019 Q4	$318K	Buy	+3,745	New	+$250K	﹤0.01%	1211
2016 Q1	–	Sell	-10,645	Closed	-$397K	–	1321
2015 Q4	$397K	Hold	10,645	–	–	﹤0.01%	767
2015 Q3	$404K	Sell	10,645 -6,191	-37%	-$217K	0.01%	693
2015 Q2	$482K	Sell	16,836 -5,442	-24%	-$152K	0.01%	692
2015 Q1	$624K	Buy	22,278 +6,202	+39%	+$174K	0.01%	642
2014 Q4	$445K	Buy	+16,076	New	+$398K	0.01%	758
2014 Q2	–	Sell	-11,239	Closed	-$319K	–	933
2014 Q1	$319K	Buy	+11,239	New	+$372K	0.01%	708

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

JP Morgan Private Wealth Advisors's MDCO Position: Q1 2020 in Review

JP Morgan Private Wealth Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 3,745 shares — an estimated $318K sold.

JP Morgan Private Wealth Advisors first reported a position in MDCO in Q1 2014 and held it in 7 quarters. The position peaked at $624K in Q1 2015. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

JP Morgan Private Wealth Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 3,745 Medicines Co shares in Q1 2020, an estimated $318K.
JP Morgan Private Wealth Advisors first reported a position in Medicines Co in Q1 2014 and held it in 7 quarters.
JP Morgan Private Wealth Advisors's Medicines Co position peaked at $624K in Q1 2015.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2020, filed 13 May 2020.